← Open Payments lookup

WYATT CLARK: Open Payments

NPI 1598462533 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,550 in 49 payments from 9 companies in 2025. Trend: 2023 $1,351 · 2024 $2,467 · 2025 $1,550

Food & beverage: $1,550
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$363
Alkermes, Inc.6$341
ABBVIE INC.13$334
E.R. Squibb & Sons, L.L.C.5$138
Janssen Pharmaceuticals, Inc2$117
Vanda Pharmaceuticals Inc.3$99
Otsuka America Pharmaceutical, Inc.4$92
Neurocrine BioSciences, Inc.2$36
Supernus Pharmaceuticals, Inc.2$29

Products named: CAPLYTA, VRAYLAR, ARISTADA, COBENFY, LYBALVI, INVEGA SUSTENNA, FANAPT, REXULTI.

Industry payments across NV — which companies pay providers there.